Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole genome sequencing of donor-derived vancomycin-resistant enterococci

ABSTRACT: Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation

PROVIDER: PRJEB40484 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4626640_1.fastq.gz	Fastqsanger.gz
	ERR4626640_2.fastq.gz	Fastqsanger.gz
	ERR4626641_1.fastq.gz	Fastqsanger.gz
	ERR4626641_2.fastq.gz	Fastqsanger.gz
	ERR4626642_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Cajanin Stilbene Acid Inhibited Vancomycin-Resistant Enterococci By Inhibiting Phosphotransferase System

Project description:In order to determine the mechanism of Cajanin Stilbene Acid inhibiting vancomycin-resistant enterococci, we compared the changes in protein expression of enterococci V583 strain before and after treated by Cajanin Stilbene Acid.

2020-05-27 | PXD017522 | Pride

Vancomycin resistant Enterococci among COVID-19 patients

Project description:Vancomycin resistant Enterococci among COVID-19 patients

| PRJEB40144 | ENA

Longitudinal collection of local vancomycin resistant enterococci

Project description:Longitudinal collection of local vancomycin resistant enterococci

| PRJEB49226 | ENA

Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation

Project description:Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation

| PRJEB83283 | ENA

Molecular typing of vancomycin-resistant enterococci

Project description:Molecular typing of vancomycin-resistant enterococci: Evaluation of a core genome MLST scheme using pulsed-field gel electrophoresis as the reference method

| PRJEB25424 | ENA

Resistant enterococci

Project description:Resistant enterococci

| PRJEB64173 | ENA

Clostridioides difficile and Vancomycin-resistant Enterococci on shoes of healthcare workers.

Project description:Toxigenic Clostridioides difficile and Vancomycin-resistant Enterococci – new mode of transmission by shoes of healthcare workers? A prospective cohort study.

| PRJEB43517 | ENA

Cervimycin resistant Staphylococcus aureus strains display a vancomycin intermediate resistant phenotype

Project description:Resistance to antibiotics is an emerging problem and necessitates novel antibacterial therapies. Cervimycins A‒D are natural products of Streptomyces tendae HKI 0179 with promising activity against multidrug resistant staphylococci and vancomycin resistant enterococci. We studied the mode of action of cervimycin C and D by selection of cervimycin resistant (CmR) Staphylococcus aureus strains. Genome sequencing of CmR mutants revealed amino acid exchanges in the essential histidine kinase WalK, the Clp protease proteolytic subunit ClpP or the Clp ATPase ClpC, and the heat shock protein DnaK. Interestingly, all characterized cervimycin resistant mutants harbored a combination of mutations in walK and clpP or clpC. Mutations in the Clp system abolished ClpP or ClpC activity, and the deletion of clpP rendered S. aureus but not B. subtilis cervimycin resistant. The essential gene walK was the second mutational hotspot in the cervimycin resistant S. aureus mutants, which decreased WalK activity in vitro and generated a vancomycin intermediately resistant phenotype, with a thickened cell wall, a slower growth rate, and reduced cell lysis. Transcriptomic and proteomic analysis revealed massive alterations in the CmR strains , with major alterations in the heat shock regulon, the metal ion homeostasis and the carbohydrate metabolism. Taken together, compensatory mutations in cervimycin resistant mutants induced a VISA phenotype in S. aureus, suggesting cell wall metabolism or the ClpCP proteolytic system as primary target of the polyketide antibiotic

2022-09-08 | GSE206309 | GEO

Enterococci

Project description:Plasmid derived mobilome sequencing of vancomycin resistant enterococci from river Ganga water

| PRJNA521376 | ENA

Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation.

Project description:BackgroundTransplant recipients are at high risk for infections. However, donor-recipient transmission of multidrug-resistant organisms (MDROs) remains mostly unaddressed in the protocols of pre-transplant infection and colonization screening. Vancomycin-resistant enterococci (VRE) are MDROs that colonize the gastrointestinal tract and are associated with a significant burden of disease. Besides the high mortality of invasive VRE infections, chronic colonization leads to costly isolation measures in the hospital setting. Whereas most post-transplantation VRE infections are endogenous and thus preceded by colonization of the recipient, conclusive evidence of VRE transmission via allograft in the context of intestinal transplantation is lacking.Case presentationWe describe a donor-derived VRE infection after intestinal transplantation including small bowel and right hemicolon. The recipient, a 54-year old male with history of mesenteric ischemia and small bowel perforation due to generalized atherosclerosis and chronic stenosis of the celiac trunk and the superior mesenteric artery, developed an intra-abdominal infection and bloodstream infection after transplantation. VRE isolates recovered from the patient as well as from the allograft prior to transplantation were analyzed via whole genome sequencing. Isolates showed to be genetically identical, thus confirming the transmission from donor to recipient.ConclusionsThis case underlines the relevance of donor-recipient VRE transmission and invasive infection in the context of intestinal transplantation, highlighting the need for preoperative MDRO screening that facilitates the prompt and effective treatment of possible infections as well as the timely establishment of contact precautions to prevent further spread.

| S-EPMC7648953 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data